Commonwealth Equity Services’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.24M | Buy |
9,926
+1,455
| +17% | +$474K | ﹤0.01% | 1643 |
|
|
2025
Q1 | $2.29M | Buy |
8,471
+1,934
| +30% | +$522K | ﹤0.01% | 1819 |
|
|
2024
Q4 | $1.54M | Buy |
6,537
+1,234
| +23% | +$290K | ﹤0.01% | 2055 |
|
|
2024
Q3 | $1.46M | Sell |
5,303
-449
| -8% | -$123K | ﹤0.01% | 2046 |
|
|
2024
Q2 | $1.4M | Buy |
5,752
+158
| +3% | +$38.4K | ﹤0.01% | 2034 |
|
|
2024
Q1 | $836K | Buy |
5,594
+1,365
| +32% | +$204K | ﹤0.01% | 2377 |
|
|
2023
Q4 | $809K | Sell |
4,229
-143
| -3% | -$27.4K | ﹤0.01% | 2319 |
|
|
2023
Q3 | $774K | Buy |
4,372
+363
| +9% | +$64.3K | ﹤0.01% | 2250 |
|
|
2023
Q2 | $761K | Buy |
4,009
+348
| +10% | +$66.1K | ﹤0.01% | 2298 |
|
|
2023
Q1 | $733 | Sell |
3,661
-1,546
| -30% | -$310 | ﹤0.01% | 2258 |
|
|
2022
Q4 | $1.24M | Buy |
5,207
+433
| +9% | +$103K | ﹤0.01% | 1820 |
|
|
2022
Q3 | $955K | Buy |
4,774
+198
| +4% | +$39.6K | ﹤0.01% | 1929 |
|
|
2022
Q2 | $667K | Sell |
4,576
-442
| -9% | -$64.4K | ﹤0.01% | 2206 |
|
|
2022
Q1 | $819K | Sell |
5,018
-193
| -4% | -$31.5K | ﹤0.01% | 2140 |
|
|
2021
Q4 | $883K | Buy |
5,211
+942
| +22% | +$160K | ﹤0.01% | 2084 |
|
|
2021
Q3 | $806K | Sell |
4,269
-103
| -2% | -$19.4K | ﹤0.01% | 2091 |
|
|
2021
Q2 | $741K | Sell |
4,372
-444
| -9% | -$75.3K | ﹤0.01% | 2153 |
|
|
2021
Q1 | $679K | Buy |
4,816
+476
| +11% | +$67.1K | ﹤0.01% | 2080 |
|
|
2020
Q4 | $564K | Sell |
4,340
-7
| -0.2% | -$910 | ﹤0.01% | 2070 |
|
|
2020
Q3 | $632K | Buy |
4,347
+133
| +3% | +$19.3K | ﹤0.01% | 1808 |
|
|
2020
Q2 | $624K | Buy |
4,214
+84
| +2% | +$12.4K | ﹤0.01% | 1731 |
|
|
2020
Q1 | $449K | Sell |
4,130
-1,470
| -26% | -$160K | ﹤0.01% | 1764 |
|
|
2019
Q4 | $644K | Sell |
5,600
-1,459
| -21% | -$168K | ﹤0.01% | 1715 |
|
|
2019
Q3 | $567K | Sell |
7,059
-37
| -0.5% | -$2.97K | ﹤0.01% | 1736 |
|
|
2019
Q2 | $514K | Buy |
7,096
+76
| +1% | +$5.51K | ﹤0.01% | 1775 |
|
|
2019
Q1 | $656K | Sell |
7,020
-2,051
| -23% | -$192K | ﹤0.01% | 1567 |
|
|
2018
Q4 | $661K | Buy |
9,071
+5,802
| +177% | +$423K | ﹤0.01% | 1459 |
|
|
2018
Q3 | $286K | Buy |
3,269
+206
| +7% | +$18K | ﹤0.01% | 2209 |
|
|
2018
Q2 | $302K | Buy |
3,063
+100
| +3% | +$9.86K | ﹤0.01% | 2116 |
|
|
2018
Q1 | $352K | Sell |
2,963
-2,910
| -50% | -$346K | ﹤0.01% | 1945 |
|
|
2017
Q4 | $746K | Sell |
5,873
-1,159
| -16% | -$147K | ﹤0.01% | 1406 |
|
|
2017
Q3 | $826K | Sell |
7,032
-267
| -4% | -$31.4K | ﹤0.01% | 1294 |
|
|
2017
Q2 | $582K | Buy |
7,299
+895
| +14% | +$71.4K | ﹤0.01% | 1468 |
|
|
2017
Q1 | $328K | Sell |
6,404
-180
| -3% | -$9.22K | ﹤0.01% | 1788 |
|
|
2016
Q4 | $247K | Buy |
6,584
+780
| +13% | +$29.3K | ﹤0.01% | 1916 |
|
|
2016
Q3 | $393K | Buy |
5,804
+100
| +2% | +$6.77K | ﹤0.01% | 1528 |
|
|
2016
Q2 | $317K | Buy |
+5,704
| New | +$317K | ﹤0.01% | 1623 |
|